Formulation and evaluation of Transdermal Patch of Antipsychotic Drug to Overcome Nervous Emotional Disease

Authors

  • Raj Soni Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.
  • Abhishek Kumar Jain Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.
  • Umesh Kumar Jain Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

DOI:

https://doi.org/10.22270/ajprd.v13i1.1497

Abstract

The transdermal drug delivery gives several benefits when compared with oral route viz. better adherence of sufferers on durable treatment, plasma drug level maintenance for an extended period of time, bypassing hepatic metabolism with reduced intra-patient variability. The outcomes of the proposed research work intimated that the proposed formulations of quetiapine provide the sustained drug delivery that, results in reduced dosage frequency. Thus, transdermal drug delivery facilitates the patient’s adherence to long-term therapy as well as reduces the hurdles of doctors and caregivers regarding the treatment of the patients. Hence, this can be proved to be a propitious opportunity that affords effective treatment of schizophrenia.The present investigation highlights the prospects of alternate route of drug delivery inthe form of transdermal patch for the treatment of schizophrenia. The present research work will be able to develop and optimize transdermal matrix patch of quetiapine.

 

Downloads

Download data is not yet available.

Author Biographies

Raj Soni, Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

Abhishek Kumar Jain, Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

Umesh Kumar Jain, Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

Bhopal Institute of Technology and Science – Pharmacy, Bhopal, M.P.

References

Picchioni M, Murray R, Clinical review on schizophrenia. Psychiatry by Ten Teach 2017;335(July):102–13.

Clemency BM, Eggleston W, Lindstrom HA. Pharmacokinetics and Pharmacodynamics of Naloxone. Acad Emerg Med. 2019;24(2):16176.

Potu AR, Pujari N, Burra S, Veerareddy PR. Formulation and evaluation of buccoadhesive quetiapine fumarate tablets. 2012;48.

Dose I, Mania-Adults, dose R, Dose M. Quetiapine fumarate- quetiapine fumarate tablet sandozinc highlights of prescribing information full prescribing information : contents.

Jondhalekar TM, Aher SS, Saudagar RB. Transethosome : Novel Vesicular Carrier for Enhanced Transdermal Drug Delivery System. 2017;10(June):1816–9.

Christian S, Autonomous C, District K, Nadu T, David SB, Raj GAG. Development Studies of Biodegradable Pressure Sensitive Adhesives from Groundnut Oil and Butylmethacrylate. 2010;3(1):40–6.

Patel JG, Solanki SS, Patel KB, Patel MP, Patel JK. Buccal Drug Delivery System : A Review. 2012;5(July):883–8. 27. Rhee Y, Huh J, Park C, Nam T, Yoon K, Chi S, et al. Conh~-~/n~. 2007;30(9):1155–61.

Matlhola K, Katataseru L, Tshweu L, Bahadur I, Makgatho G, Balogun M. Formulation and Optimization of Eudragit RS PO-Tenofovir Nanocarriers Using Box-Behnken Experimental Design. 2015;2015.

Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit w E PO / Eudragit w L 100-55 interpolyelectrolyte complexes. 2006; 63:26–36.

Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272(1–2):1–10.

Rinaldi R., Bersani G., Marinelli E., Zaami S. The rise of new psychoactive substances and psychiatric implications: A wide-ranging, multifaceted challenge that needs far-reaching common legislative strategies. Hum. Psychopharmacol. Clin. Exp. 2020;35:e2727.

Gupta A., Kumar Y., Zaheer M.R., Roohi, Iqbal S., Iqbal J. Electron Transfer-Mediated Photodegradation of Phototoxic Antipsychotic Drug Quetiapine. ACS Omega. 2021;6:30834–30840.

Akamine Y., Yasui-Furukori N., Uno T. Drug-drug interactions of P-gp substrates unrelated to CYP metabolism. Curr. Drug Metab. 2019;20:124–129.

Tran J., Gervase M.A., Evans J., Deville R., Dong X. The stability of quetiapine oral suspension compounded from commercially available tablets. PLoS ONE. 2021;16:e0255963.

Burns M.J. The pharmacology and toxicology of atypical antipsychotic agents. J. Toxicol. Clin. Toxicol. 2001;39:1–14. doi: 10.1081/CLT-100102873.

Published

2025-02-15

How to Cite

Soni, R., Jain, A. K., & Jain, U. K. (2025). Formulation and evaluation of Transdermal Patch of Antipsychotic Drug to Overcome Nervous Emotional Disease. Asian Journal of Pharmaceutical Research and Development, 13(1), 15–20. https://doi.org/10.22270/ajprd.v13i1.1497